Josep Antoni Ramos‐Quiroga
A5023235716- Attention Deficit Hyperactivity Disorder
- Bipolar Disorder and Treatment
- Functional Brain Connectivity Studies
- Autism Spectrum Disorder Research
- Child and Adolescent Psychosocial and Emotional Development
- Neural and Behavioral Psychology Studies
- Neurotransmitter Receptor Influence on Behavior
- Genetics and Neurodevelopmental Disorders
- Genetic Associations and Epidemiology
- Schizophrenia research and treatment
- Treatment of Major Depression
- Children's Physical and Motor Development
- Suicide and Self-Harm Studies
- Digital Mental Health Interventions
- Tryptophan and brain disorders
- Personality Disorders and Psychopathology
- Psychology Research and Bibliometrics
- Obsessive-Compulsive Spectrum Disorders
- COVID-19 and Mental Health
- Substance Abuse Treatment and Outcomes
- EEG and Brain-Computer Interfaces
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Maternal Mental Health During Pregnancy and Postpartum
- Eating Disorders and Behaviors
- Mental Health Research Topics
Universitat Autònoma de Barcelona
2016-2025
Centro de Investigación Biomédica en Red de Salud Mental
2016-2025
Vall d'Hebron Institut de Recerca
2016-2025
Instituto de Salud Carlos III
2015-2025
Vall d'Hebron Hospital Universitari
2016-2025
Centre for Biomedical Network Research on Rare Diseases
2016-2025
Centro de Investigación Biomédica en Red
2021-2024
Massachusetts Department of Mental Health
2024
Women and Children’s Health Research Institute
2024
University of Alberta
2024
Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD currently underdiagnosed undertreated in many European countries, leading to chronicity symptoms impairment, due lack of, or ineffective treatment, higher costs illness. Methods The Network Adult Section for Neurodevelopmental Disorders Across Lifespan (NDAL) Psychiatric Association (EPA), aim increase awareness...
Available studies vary in their estimated prevalence of attention deficit/hyperactivity disorder (ADHD) substance use (SUD) patients, ranging from 2 to 83%. A better understanding the possible reasons for this variability and effect change DSM-IV DSM-5 is needed.A two stage international multi-center, cross-sectional study 10 countries, among patients form inpatient outpatient addiction treatment centers alcohol and/or drug patients. total 3558 seeking SUD were screened adult ADHD. subsample...
Spontaneous fluctuations can be measured in the brain that reflect dissociable functional networks oscillating at synchronized frequencies, such as default mode network (DMN). In contrast to its diametrically opposed task‐positive counterpart, DMN predominantly signals during a state of rest, and inappropriate regulation this has been associated with inattention, core characteristic attention‐deficit/hyperactivity disorder (ADHD). To examine whether abnormalities identified component...
Abstract Aims To determine comorbidity patterns in treatment‐seeking substance use disorder ( SUD ) patients with and without adult attention deficit hyperactivity ADHD ), an emphasis on subgroups defined by subtype, taking into account differences related to gender primary of abuse. Design Data were obtained from the cross‐sectional I nternational Substance Prevalence IASP study. Setting Forty‐seven centres treatment 10 countries. Participants A total 1205 patients. Measurements Structured...